Medicxi Ventures Management (Jersey) LTD Centessa Pharmaceuticals PLC Transaction History
Medicxi Ventures Management (Jersey) LTD
- $481 Million
- Q3 2024
A detailed history of Medicxi Ventures Management (Jersey) LTD transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, Medicxi Ventures Management (Jersey) LTD holds 19,963,157 shares of CNTA stock, worth $338 Million. This represents 66.33% of its overall portfolio holdings.
Number of Shares
19,963,157
Previous 19,963,157
-0.0%
Holding current value
$338 Million
Previous $180 Million
77.08%
% of portfolio
66.33%
Previous 64.35%
Shares
3 transactions
Others Institutions Holding CNTA
# of Institutions
108Shares Held
118MCall Options Held
5.9KPut Options Held
53K-
Index Venture Life Associates Vi LTD St. Helier, Y99.96MShares$169 Million100.0% of portfolio
-
General Atlantic LLC New York, NY9.68MShares$164 Million4.42% of portfolio
-
Perceptive Advisors LLC New York, NY6.28MShares$106 Million2.62% of portfolio
-
First Light Asset Management, LLC Edina, MN5.94MShares$101 Million8.27% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.68MShares$79.3 Million0.01% of portfolio
About Centessa Pharmaceuticals plc
- Ticker CNTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,339,296
- Market Cap $1.6B
- Description
- Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...